Medical Oncologist
Treatment costs
Lenvatinib Price in India: — Brand, Generic and Monthly Cost
The monthly cost of lenvatinib varies widely depending on whether you take the originator brand or an Indian generic. Understanding the difference — and what schemes can reduce it — is the first practical step after a prescription.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Two very different price bands — The originator brand and Indian generics differ substantially in cost. Both contain the same active ingredient at the same dose.
- Your prescribed dose sets the monthly quantity — Lenvatinib is prescribed in different strengths for different cancers. The dose, not the brand, determines how many packs you need each month.
- Assistance programmes exist — The originator manufacturer and several government schemes can reduce out-of-pocket cost for eligible patients.
- Insurance cover varies — Some policies cover oral chemotherapy; many older policies exclude it. Checking before the first prescription avoids surprises.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
At common doses, originator brand Lenvima costs roughly ₹1.5 lakh to ₹3 lakh per month in India, as of mid-2025. Indian generics from manufacturers such as Natco are available at approximately ₹15,000 to ₹50,000 per month at equivalent doses. Prices vary by pharmacy, city, and the strength your oncologist has prescribed.
What does lenvatinib cost per month in India?
| What you buy | Lenvima (originator) | Indian generic | Indicative as of |
|---|---|---|---|
| 4 mg capsules, 30 per pack | ₹60,000–₹90,000 per pack | ₹7,000–₹14,000 per pack | Mid-2025 |
| 10 mg capsules, 30 per pack | ₹1,60,000–₹2,60,000 per pack | ₹18,000–₹35,000 per pack | Mid-2025 |
| Typical monthly spend, lower prescribed dose | ₹1,20,000–₹1,80,000 | ₹14,000–₹28,000 | Mid-2025 |
| Typical monthly spend, standard prescribed dose | ₹1,60,000–₹2,60,000 | ₹18,000–₹35,000 | Mid-2025 |
| Typical monthly spend, higher prescribed dose | ₹3,20,000–₹5,20,000 | ₹36,000–₹70,000 | Mid-2025 |
Originator brand versus Indian generic: what is actually different?
| Feature | Lenvima (Eisai, originator) | Indian generics (e.g., Natco, MSN, Hetero) |
|---|---|---|
| Active ingredient | Lenvatinib mesylate | Lenvatinib mesylate |
| Regulatory approval | CDSCO-approved | CDSCO-approved |
| Indicative monthly cost, standard dose | ₹1.6 lakh–₹2.6 lakh | ₹18,000–₹35,000 |
| Patient assistance programme | Yes — Eisai has run programmes for eligible patients in India | Not typically available from generic manufacturers |
| Availability | Most hospital and larger retail pharmacies | Available, though stock varies by city and supplier |
| Can you switch without telling your oncologist? | No — always inform your team first | No — always inform your team first |
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Know the cost before you commit
An itemised estimate, plus a check of which schemes you may qualify for.
How do you reduce your monthly lenvatinib cost?
- Ask your oncologist whether an Indian generic is clinically appropriate before making any change.
- Ask your oncologist's coordinator about the Eisai patient assistance programme if you are currently on brand Lenvima.
- Apply for Ayushman Bharat PM-JAY if you have not — oral chemotherapy coverage varies by state and empanelled hospital, so confirm before assuming.
- Check your health insurance policy under the chemotherapy or cancer treatment clause for oral medicines.
- Ask about state cancer assistance schemes — both Telangana and Andhra Pradesh have their own programmes for eligible residents.
- Compare prices at your treating hospital's pharmacy and at least one other licensed pharmacy — the same generic can vary meaningfully.
How do you switch from Lenvima to a lower-cost generic?
Confirm with your oncologist
Tell them you want to discuss a generic option. They will confirm which CDSCO-approved generics are available and whether switching is suitable given your current stage of treatment.
Ask for a molecule-name prescription
A prescription written as 'lenvatinib 10 mg' rather than 'Lenvima 10 mg' allows the pharmacist to dispense a generic. Ask your oncologist to write it this way if they agree to the switch.
Verify the pharmacy and the product
Hospital pharmacies affiliated with licensed cancer centres generally carry verified stock. Ask the pharmacist for the manufacturer's name and confirm the product holds a valid CDSCO batch approval. Avoid unverified online sources — counterfeit oral oncology medicines are a documented risk in India.
Report any change at your next visit
After switching, tell your team if anything changes — side effects, tolerability, or how you generally feel on the drug. Your team interprets every symptom and scan result in the context of exactly what you are taking.
Does insurance or a government scheme cover lenvatinib?
Ayushman Bharat PM-JAY covers cancer treatment at empanelled hospitals, but whether oral chemotherapy is included depends on your state's implementation and the specific hospital's empanelment category. Ask the hospital's insurance desk directly before collecting your first prescription — not after.
Private health insurance policies vary widely. Many now include oral chemotherapy, but older policies still exclude it or treat it differently from medicines given during a hospital admission. Read the chemotherapy clause in your policy, or ask your insurer in writing so you have a clear answer.
Both Telangana and Andhra Pradesh run cancer patient support schemes for eligible residents. Your oncology team's social worker or the patient services desk at your treating centre can tell you what is currently available and help with the application.
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Is the Indian generic version of lenvatinib as effective as Lenvima?
A CDSCO-approved generic must meet bioequivalence standards — it contains the same active ingredient at the same dose and must behave the same way in your body as the originator. That is the basis on which it receives approval. Your oncologist is still the right person to confirm whether switching is appropriate for your situation, because your stage of treatment and how well you have been tolerating the current product both matter in that decision.
Can I switch from Lenvima to a generic once I have already started treatment?
Speak to your oncologist before switching. Mid-treatment changes are not automatically unsafe, but your team needs to know so they can monitor you properly and record the change accurately. Do not switch and tell them later — not because the switch is dangerous, but because your team interprets every symptom and scan result in the context of exactly what you are taking.
Is there a patient assistance programme for lenvatinib in India?
Eisai, the originator manufacturer, has run patient assistance programmes for Lenvima in India. These programmes change over time, so the best way to find out the current status is to ask your oncologist's coordinator to check and, if you are eligible, help you apply. Generic manufacturers do not typically run equivalent programmes, but the substantially lower cost of generics serves the same practical purpose for many patients.
Does PM-JAY cover lenvatinib?
Coverage depends on your state's implementation and the empanelment category of your treating hospital. The fastest way to get a clear answer is to ask the hospital's insurance or billing desk before you collect your first prescription. If your treating hospital is not empanelled under PM-JAY, ask whether you can be referred to one that is for the purpose of the scheme.
Why does the price vary so much between pharmacies?
Oncology drug pricing in India is not uniformly regulated for all products. Hospital pharmacies may procure at different volumes and apply different margins; some hospital pharmacies offer concessional rates for patients undergoing treatment at that centre. Calling two or three pharmacies before filling the prescription — including the hospital pharmacy at your treating centre — typically surfaces the best available price for the pack and strength you need.
What should I do if I cannot afford the first month's prescription?
Tell your oncologist immediately — not after skipping a dose. Most cancer centres have a social worker or patient services coordinator whose job is to find a path forward: a manufacturer programme, a government scheme, a hospital fund, or a generic substitution. Missing doses because of cost is one of the most common and most preventable treatment interruptions. Your team can only help if they know.